Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1861657 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $2.04Day +0.49%Mkt cap $142MOff 52W high −61.3%Vol (1Y) 91.9%
Daily closing price, split-adjusted to the current basis; 0.4y shown of 101 bars on file. Sampled to 101 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest11.1% of sh out |
| Days to cover11.8d |
| 13F net flow (QoQ)−0.56% |
| Top-10 13F concentration79.9% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$80.7M |
| ROE−18.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
No return windows available for CNTN.
| Ann. volatility (1Y)91.9% |
| Ann. volatility (3Y)91.9% |
| Sharpe (1Y)−1.94 |
| Sharpe (3Y)−1.94 |
| Max drawdown (1Y)−62.3% |
| Max drawdown (3Y)−62.3% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ARK Investment Management LLC | 3.7M | $12M | 5.29% | +13.6% |
| Valor Management LLC | 1.1M | $4M | 1.55% | new |
| BlackRock, Inc. | 765,829 | $3M | 1.10% | +0.0% |
| Amova Asset Management Americas, Inc. | 728,167 | $2M | 1.04% | new |
| Sumitomo Mitsui Trust Group, Inc. | 728,167 | $2M | 1.04% | new |
| Clear Street Group Inc. | 652,243 | $2M | 0.93% | −61.0% |
| RENAISSANCE TECHNOLOGIES LLC | 562,000 | $2M | 0.81% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 452,680 | $1M | 0.65% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.23 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.34 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.64 | — | — | — |
| 2025-03-31 | 2025-05-12 | −$0.99 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
